Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.gastrohep.2017.11.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Venous thrombosis in unusual sites: A practical review for the hematologist.
Eur J Haematol
January 2019
Division of Hematology-Oncology, Oregon Health & Science University, Portland, Oregon.
Thrombosis of unusual venous sites encompasses a large part of consultative hematology and is encountered routinely by practicing hematologists. Contrary to the more commonly encountered lower extremity venous thrombosis and common cardiovascular disorders, the various thromboses outlined in this review have unique presentations, pathophysiology, workup, and treatments that all hematologists should be aware of. This review attempts to outline the most up to date literature on cerebral, retinal, upper extremity, hepatic, portal, splenic, mesenteric, and renal vein thrombosis, focusing on the incidence, pathophysiology, provoking factors, and current recommended treatments for each type of unusual thrombosis to provide a useful and practical review for the hematologist.
View Article and Find Full Text PDFPortal-splenic-mesenteric venous thrombosis in a patient with Klinefelter syndrome.
Gastroenterol Hepatol
November 2018
Unidad de Hepatología, Servicio de Aparato Digestivo, Hospital Germans Trias i Pujol, Badalona, Barcelona, España. Electronic address:
Thromboembolic Events Following Splenectomy: Risk Factors, Prevention, Management and Outcomes.
World J Surg
March 2018
Department of Hematology, Hadassah-Hebrew University Medical Center, POB 12000, 91120, Jerusalem, Israel.
Background: Thromboembolic events following splenectomy are not uncommon. However, the role of thromboprophylaxis and risk factors for thrombosis, as well as the clinical course and outcomes, are not well characterized.
Methods: A retrospective review of individuals who underwent splenectomy between January 2006 and December 2015 in two university hospitals.
Factors associated with thromboembolic events following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
J Surg Oncol
December 2017
Department of General and Oncological Surgery- Surgery C, The Chaim Sheba Medical Center, Ramat Gan, Israel.
Background And Objectives: We investigated the risk factors, incidence, and role of thromboprophylaxis in the development of thrombosis following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).
Methods: We reviewed data of patients with CRS/HIPEC in three hospitals.
Results: Overall, 192 patients underwent CRS/HIPEC during 2007-2016.
Abdominal thrombotic complications following bariatric surgery.
Surg Obes Relat Dis
January 2017
Hematology Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. Electronic address:
Background: Thrombotic events involving the portal-splenic-mesenteric venous system (PSMVT) are rare but potentially lethal after bariatric surgery.
Objectives: To investigate the incidence, clinical presentation, management, and outcome of thrombotic events after bariatric surgery.
Setting: Two university hospitals.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!